Many membrane transport systems are altered by changes in the state of the actin cytoskeleton. While an intact microtubule network is required for hypertonic activation of the betaine transporter (BGT1), the possible role of the actin cytoskeleton is unknown.
BGT1 function in MDCK cell monolayers was assessed as Na Immunofluorecence staining revealed colocalization of BGT1 and F-actin at the plasma membrane of hypertonic cells. Surface biotinylation revealed no major change in BGT1 protein abundance after cytochalasin D action, suggesting that stimulation of hypertonic activation of BGT1 transport is due to increased activity of existing BGT1 transporters.
INTRODUCTION
When exposed to hypertonic stress, cells regulate their volume initially by ion accumulation. During prolonged hypertonicity, this step is followed by amino acid accumulation and eventually by accumulation of organic solutes or osmolytes. The intracellular accumulation of osmolytes does not disrupt metabolic pathways or interrupt protein synthesis, in contrast to the accumulation of ions and amino acids. Betaine is an osmolyte which enters cells via the betaine transporter (BGT1) which also transportsaminobutyric acid (GABA) (21). BGT1 is found in many mammalian tissues, including the brain (5) , and is abundant in cells of the inner renal medulla where it is located in the basolateral membrane (27; 36). Renal medullary cells are routinely exposed to the high hypertonicity which is an important component of the urinary concentrating mechanism.
The activity of BGT1 is upregulated in response to prolonged (24 h) hypertonic stress (26; 36), and this is an important part of the overall adaptation that allows the medullary cells to balance the osmotic stress across the plasma membrane (6) .
The activities of many membrane transporters have been shown to be affected by changes in the state of the actin cytoskeleton (16), suggesting a possible regulatory role for actin (24) . For example, the open probability of the voltage dependent Na + channel in rabbit cardiac myocytes is decreased when the actin cytoskeleton was disrupted by cytochalasin D (33), and in rat hippocampal neurons the Ca 2+ influx by the Ca containing 10% bovine calf serum, 10 mM Hepes, 25 mM NaHCO 3 (pH 7.4) and penicillin G (100 U/ml), as in previous studies (3; 18). Cultures were maintained at 37 o C in an atmosphere of 5% CO 2 in air. Cells were grown on glass coverslips for immunofluorescence studies, and in 6-well plates for transport measurements.
Hypertonic stress was induced by replacing normal growth medium with growth medium made hypertonic by addition of sucrose to achieve a final osmolality of 500 mosmol/kg, as in previous studies (3) . The osmolality of all solutions used for transport was matched to the osmolality of the growth medium by addition of sucrose where Colocalization of actin and BGT1 proteins. Cell monolayers were rinsed in PBS as above, and some were extracted with a cytoskeleton stabilizing buffer containing 1% triton X-100, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl 2 , 1 mM EGTA, and protease inhibitors (Halt kit, Pierce, Rockford, IL) for 15 min on ice (34). All samples were fixed by immersion for 10 min in cold methanol, as described previously (3) . A 30 min preincubation in 2% gelatin in PBS was followed by a two-hour incubation in affinity- to a protein concentration of 1 mg/ml, and biotinylated proteins were precipitated by addition of 100 l of a slurry of streptavidin-coupled agarose (Pierce) followed by incubation with rotation at room temperature for 1 h. In order to prevent non-specific binding, the agarose beads were previously incubated with PBSCM containing 2% bovine serum albumin, followed by four washes with PBSCM. The triton supernatant was centrifuged to pellet the beads, and the supernatant was stored at -80 o C . The beads were washed four times in the triton lysis buffer, mixed with an equal volume of 2 x electrophoresis sample buffer (3), heated at 65 o C for 15 min, and subjected to gel electrophoresis and western blotting as described previously (3) . Rabbit antibodies to dog BGT1 and mouse E-cadherin, generously provided by Drs. Moo Kwon (Johns Hopkins University School of Medicine) and James Marrs (Indiana University School of Medicine), were used at dilutions of 1:1,500 and 1:10,000, respectively. Mouse monoclonal antibody to actin (Sigma) was used at 1:1,000. Secondary antibodies conjugated to horseradish peroxidase and ECL reagents (Amersham) were used for detection. Short exposures of the Western blots that were not saturating were used for quantitation. Films were scanned with a BioRad GS-670 imaging densitometer (3).
RESULTS
In MDCK cells maintained in isotonic medium there was no significant Na transport in cells exposed to hypertonic medium containing 4 M phalloidin for 24 h was not different compared to activation by hypertonic medium alone (Fig. 4 ).
Since cytochalasin B was shown previously to inhibit glucose transporters (29), it was important to verify that the stimulation of BGT1 transport by cytochalasin D and latrunculin A was due primarily to actin destabilization. The possible direct action of these drugs on BGT1 transport was tested by including them in the GABA uptake medium instead of the cell growth medium. The hypertonic activation of BGT1 transport remained unchanged during this relatively brief 10 min exposure to either drug (Fig. 5 ),
indicating that neither cytochalasin D nor latrunculin A had any direct effect on the BGT1 transporter. Phalloidin also had no effect on BGT1 transport when tested in this way (Fig. 5) .
In order to determine if an intact cytoskeleton is a specific requirement for hypertonic regulation of the BGT1 transporter, alanine uptake in MDCK cells was studied. We have shown previously that amino acid system A, a major route for alanine uptake in MDCK cells, is upregulated within 5 h after exposure to hypertonic stress (9).
Cells were treated with hypertonic cell growth medium containing presence of cytochalasin D in the isotonic medium for either 24 h or 48 h had no effect on downregulation of BGT1 transport (Fig. 7) . This strongly suggests that the stimulatory action of cytochalasin D on the hypertonic activation of BGT1 transport is not due to blocking retrieval of BGT1 transporters from the membrane.
The next experiments focused on the upregulation of BGT1 transport, and used surface biotinylation to determine if cytochalasin D increased the abundance of BGT1 protein in the plasma membrane. As expected, no BGT1 protein was detected at the cell surface under isotonic conditions, but there was a marked increase in surface BGT1 after hypertonic stress (Fig. 8) . Cytochalasin D produced no major change in surface BGT1 abundance under either isotonic or hypertonic conditions. Blots were stripped and reprobed with antibody to E-cadherin, a loading control. E-cadherin was biotinylated under all conditions and its abundance did not change (Fig. 8) . In each sample lane the densities of the BGT1 and E-cadherin signals were quantitated by densitometric scans.
Based on six separate experiments, the BGT1/cadherin ratio was 3.9 + 0.6 (mean + S.E.)
for hypertonic cells and 4. The possibility that biotin may have access to an intracellular pool of BGT1 in hypertonic or drug treated cells was tested by probing for actin, an intracellular protein (37). Although actin was very abundant in the initial triton lysate (prior to streptavidin treatment), almost no actin was detectable in the protein fractions recovered on streptavidin beads (Fig. 9 ). This indicates that biotinylation of intracellular proteins was negligible and was not affected by cytochalasin D. Thus, the data in Fig. 8 are not complicated by labeling of intracellular BGT1 which might mask a change in surface labeling.
The possibility of a physical interaction between F-actin and BGT1 in MDCK cells was tested by colocalization using dual antibody staining. Under isotonic conditions there was little evidence of stress fibers in confluent cells, most of the F-actin stain was cytosolic (Fig. 10A) . The same was true for BGT1 staining (Fig 10B) , and this was confirmed by the merged image (Fig. 10C) . Triton extraction removed most of the cytosolic staining, only cortical F-actin remained (Figs. 10D-E) , and there was little or no overlap (Fig. 10F) . Following 24 h of hypertonic stress, most of the F-actin was distributed around the cell periphery in the cortical pool (Fig. 10G) . As expected, most of the BGT1 stain was in the plasma membrane (Fig. 10H) where there was pronounced colocalization with cortical actin ( (Fig. 10M ). In contrast, there was no noticeable change in BGT1 distribution ( Fig. 10N ) resulting in a marked decrease in colocalization (Fig. 10O ). As expected, the combination of cytochalasin D and triton treatment removed more F-actin than either treatment alone (Fig. 10P) , and all of the BGT1 (Fig. 10Q ).
Antibody staining of BGT1 in plasma membranes was heterogeneous between different cells in the same field of view (Fig. 10H ) making quantitation difficult. Overall, there appeared to be no clear cut differences in the intensity of the BGT1 fluorescence in the plasma membranes shown in panels H (hypertonic) and N (hypertonic + cytochalasin D) of Fig. 10 .. This is at least consistent with the biotinylation data which provide a much better quantitative comparison of surface BGT1 (Fig. 8) . Several studies suggest that the organization of the actin cytoskeleton is important for cell volume regulation, and is altered by changes in cell size (15). For example, the cytoskeleton of CHO cells showed marked reorganization within 10 min after increasing medium osmolality to 500 mosmol/kg (30). Since immunochemical staining revealed the presence of intracellular BGT1 proteins under isotonic conditions (3), the question arose that some of these pre-existing proteins might gain access to the plasma membrane during the initial exposure to hypertonicity and while the cytoskeleton was being reorganized. This initial response to hypertonicity may be independent of the presence of depolymerizing drugs. This possibility was investigated by using the F-actin stabilizing drug phalloidin. The presence of phalloidin did not inhibit the normal increase in BGT1 transport activity in response to 24 h hypertonic stress (Fig. 4) , suggesting that the increase in BGT1 transport due to 24 h hypertonicity is unlikely to be caused simply by the initial disruption of the actin cytoskeleton. Induction of BGT1 transport during hypertonicity occurs principally through activation of BGT1 gene transcription by the transcription factor TonEBP, as reported previously (14; 32).
The mechanism by which the cytoskeleton is involved in upregulation of BGT1 transport has not been established. It does not appear to be required for downregulation of BGT1 transport when cells were returned to isotonic medium after 24h of hypertonicity (Fig. 7) . There are at least two possible mechanisms to consider. First, the actin cytoskeleton may act as a barrier or fence that restricts the access of BGT1 proteins to the plasma membrane, as suggested for aquaporin-2 (12). Disruption of the actin cytoskeleton causes breaks in the fence, which may allow more BGT1 proteins to be inserted into the plasma membrane during upregulation by hypertonic stress. This mechanism seems very unlikely because it would lead to an increased abundance of BGT1 in the plasma membrane. The biotinylation studies revealed no major change in surface expression of BGT1 protein following exposure to cytochalasin D. Further, the upregulation of Na + /alanine cotransport was not stimulated by cytochalasin D, and it is difficult to understand why removal of a potential barrier would only affect upregulation of BGT1.
The second, and more likely explanation, is that the actin cytoskeleton may serve to inhibit BGT1 transport activity through direct interactions with the transporter protein.
In MDCK cells, for example, the Na 
